FDA Request For Help On Hemp Regulation Gets Lower Profile In House Appropriators' Report

Committee’s report published with FY2025 appropriation states a different approach to establishing FDA regulation of non-drug products containing hemp as a derivative of cannabis de-scheduled as controlled substance in the US since 2018.